News explainer

Saxenda is being discontinued in the US, with last shipments to wholesalers in late January 2027

Key numbers

Result
Last Saxenda shipments to US wholesalers take place in late January 2027.
Date
Notice read on Nov 20, 2026 on Novo Nordisk's prescriber site. The page does not give the date it was first posted.
Announced by
Novo Nordisk: Novo Nordisk discontinuation notice
Note
Novo says the decision "is not the result of any safety or quality-related concerns."
Eduard Cristea
Eduard Cristea
Published:
A pharmacy storeroom shelf with one section nearly empty

What happened

Novo Nordisk's prescriber site carries an advance notice: "we will be discontinuing Saxenda® in the US, with last shipments to wholesalers taking place in late January 2027" (Novo Nordisk).

Novo gives the reason plainly: more FDA-approved treatment options have become available and the number of people using Saxenda has kept falling, so it made a portfolio decision to discontinue the brand. It says the decision is not about safety or quality, and asks prescribers to talk with patients about alternative treatments.

Saxenda (liraglutide) is a daily injection. The newer options include weekly injections such as Wegovy and Zepbound and daily pills such as the Wegovy pill and Foundayo. Our Saxenda guide covers the switch in more detail.

What this means for cost

If you are moving off Saxenda, these are today's prices on our records for the main options. Your prescriber chooses the drug and the strength.

Cash prices on our records
OptionCash price on our recordRead
Wegovy (semaglutide), Novo NordiskPen: $199 a month for the first 2 fills at 0.25 mg or 0.5 mg for new patients, through December 31, 2026, then $349. Pill: $149 at 1.5 mg, $199 at 4 mg, $299 at 9 mg and 25 mg.Maker's page, Nov 6, 2026
Foundayo (orforglipron), Eli LillyThrough LillyDirect: from $149 a month at 0.8 mg and 2.5 mg, $199 at 5.5 mg, $299 at higher doses.Maker's page, Nov 6, 2026
Zepbound (tirzepatide), Eli LillyKwikPen through LillyDirect: from $299 a month at 2.5 mg, $399 at 5 mg, $449 at higher doses.Maker's page, Nov 6, 2026
EmbodyCompounded semaglutide$79/mo, medication plus recorded program feeRecorded Nov 6, 2026
CoreAge RxCompounded semaglutide$79/mo, medication plus recorded program feeRecorded Nov 6, 2026
AgelessRxCompounded semaglutide$139/mo, medication plus recorded program feeDate not recorded
EmbodyCompounded tirzepatide$129/mo, medication plus recorded program feeRecorded Nov 6, 2026
CoreAge RxCompounded tirzepatide$129/mo, medication plus recorded program feeRecorded Nov 6, 2026
Sprout HealthCompounded tirzepatide$199 per 4 weeks, medication plus recorded program feeRecorded Nov 6, 2026

Compounded rows are the lowest recorded monthly subtotals among active listings, sorted by price: medication plus any recorded program fee, with other costs such as labs or shipping not included. Compounded medications are not FDA-approved and are not the brand products. Your prescriber decides which drug and strength fit you.

What happens next

  1. Now to late January 2027

    Pharmacies keep filling Saxenda from wholesaler stock. A good time to plan a switch with your prescriber.

  2. Late January 2027

    Last shipments to US wholesalers. After that, supply depends on what pharmacies still hold.

Sources

  1. Novo Nordisk, Saxenda prescriber site, discontinuation notice, read Nov 20, 2026

Embody

from $49/mo, 12-month plan

Visit Embody